Purpose of the Profile
- Early detection of fat accumulation in the liver before complications arise.
- Accurate assessment of liver fibrosis using FibroScan technology.
- Identification of metabolic risk factors associated with liver disease.
Safeguard your liver from fatty disease with our comprehensive screening profile, combining advanced laboratory tests and imaging technology to ensure early detection and effective prevention of chronic liver conditions.
Scientific name: Non-Alcoholic Fatty Liver Disease (NAFLD) Screening Profile
A comprehensive program including metabolic panels, FibroScan (VCTE), and hepatic ultrasound for accurate detection of fat accumulation and fibrosis associated with Non-Alcoholic Fatty Liver Disease (NAFLD).